Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section

NCT02936661 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT02936661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02936661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2017
Completion date
March 31, 2019
Enrollment
6,700 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage， cesarean section